Early Disease Risk, Treatment & Nutrition Biomarkers

Discovery pipeline build using omics technologies together with data science to address infertility, pelvic floor conditions and maternal health risks.

State-of-the-art Omics Technologies

Application of high-throughput genomics analysis to discover new disease and treatment biomarkers.

Genomics and Epigenomics

DNA variants and gene expression analysis to determine early detection of pregnancy complications and pelvic floor conditions.

Pharmacogenomics

Analysis of DNA markers to personalize medications to treat infertility, pelvic pain, gestational diabetes and depression.

Nutrigenomics

Analysis of DNA markers to identify nutrition needs and personalize dietary plans to prevent pregnancy complications and alleviate pelvic pain.

AI and SaaS

Digital health platform for early diagnosis and personalized prevention of pregnancy complications, as well as chronic gynecological conditions associated with pelvic pain and infertility. The software works in conjunction with our custom-designed non-invasive genomics testing and bioinformatics.

Non-Invasive Lab Testing

DNA Testing

Lab testing is conducted at a CLIA-certified laboratory and includes analysis of DNA variants related to included in the panel diseases predisposition, as well as nutritional markers to optimize diet.

Custom Bioinformatics

Data analysis and interpretation are performed using proprietary computational algorithms.

Supporting physicians by translating genomics and omics data into an actionable format is crucial for improving clinical care

Clinical Decision Support Software

for Physicians

Simplified DNA Results

Complex genomics data is interpreted into actionable insights, enhancing the effectiveness of DNA testing in patient care.

Recommendations

The software delivers highly personalized dietary and treatment recommendations tailored to each individual patient. These guidelines are crafted by our clinical expert to ensure optimal care.

Page updated

Report abuse